ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets rare and Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing an investigational drug called tarlatamab in adults with advanced cancers that have a specific protein called DLL3. The goal is to see if the drug is safe and can shrink these hard-to-treat tumors. Participants will receive the drug until their cancer worsen…
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 22:59 UTC
-
New cancer drug enters human testing
Disease control Recruiting nowThis early-stage study is testing an experimental drug called MDX2004 in people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors. It will enroll about 235 …
Matched conditions: ADVANCED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope pill tested for tough cancers
Disease control Recruiting nowThis is the first study in humans of an experimental oral medication called AL58805 for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the highest safe dose and understand how the drug moves through the body. Th…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New cancer drug enters first human safety tests
Disease control Recruiting nowThis is a first-in-human study to test the safety and side effects of an experimental drug called SIBP-A10 in people with advanced cancers that have spread. Researchers will give increasing doses to up to 160 participants to find the highest dose that is safe and tolerable. The m…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC